Pharmacological inhibition or genetic ablation of PAI-1 in mice protects them from both obesity and insulin resistance while improving adipocyte health and decreasing adipose inflammation (96–99). This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.